Literature DB >> 31700170

SGLT-2 inhibitors in heart failure: a new therapeutic avenue.

Muthiah Vaduganathan1, Javed Butler2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31700170     DOI: 10.1038/s41591-019-0647-4

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  2 in total

1.  Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.

Authors:  John J V McMurray; Scott D Solomon; Silvio E Inzucchi; Lars Køber; Mikhail N Kosiborod; Felipe A Martinez; Piotr Ponikowski; Marc S Sabatine; Inder S Anand; Jan Bělohlávek; Michael Böhm; Chern-En Chiang; Vijay K Chopra; Rudolf A de Boer; Akshay S Desai; Mirta Diez; Jaroslaw Drozdz; Andrej Dukát; Junbo Ge; Jonathan G Howlett; Tzvetana Katova; Masafumi Kitakaze; Charlotta E A Ljungman; Béla Merkely; Jose C Nicolau; Eileen O'Meara; Mark C Petrie; Pham N Vinh; Morten Schou; Sergey Tereshchenko; Subodh Verma; Claes Held; David L DeMets; Kieran F Docherty; Pardeep S Jhund; Olof Bengtsson; Mikaela Sjöstrand; Anna-Maria Langkilde
Journal:  N Engl J Med       Date:  2019-09-19       Impact factor: 91.245

2.  SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis.

Authors:  Brendon L Neuen; Tamara Young; Hiddo J L Heerspink; Bruce Neal; Vlado Perkovic; Laurent Billot; Kenneth W Mahaffey; David M Charytan; David C Wheeler; Clare Arnott; Severine Bompoint; Adeera Levin; Meg J Jardine
Journal:  Lancet Diabetes Endocrinol       Date:  2019-09-05       Impact factor: 32.069

  2 in total
  3 in total

1.  Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients With Heart Failure With Reduced Ejection Fraction in US Clinical Practice: The Get With the Guidelines-Heart Failure (GWTG-HF) Registry.

Authors:  Muthiah Vaduganathan; Stephen J Greene; Shuaiqi Zhang; Maria Grau-Sepulveda; Adam D DeVore; Javed Butler; Paul A Heidenreich; Joanna C Huang; Michelle M Kittleson; Karen E Joynt Maddox; James J McDermott; Anjali Tiku Owens; Pamela N Peterson; Scott D Solomon; Orly Vardeny; Clyde W Yancy; Gregg C Fonarow
Journal:  JAMA Cardiol       Date:  2020-11-13       Impact factor: 14.676

Review 2.  Anti-Diabetic Therapy, Heart Failure and Oxidative Stress: An Update.

Authors:  Ioanna Koniari; Dimitrios Velissaris; Nicholas G Kounis; Eleni Koufou; Eleni Artopoulou; Cesare de Gregorio; Virginia Mplani; Themistoklis Paraskevas; Grigorios Tsigkas; Ming-Yow Hung; Panagiotis Plotas; Vaia Lambadiari; Ignatios Ikonomidis
Journal:  J Clin Med       Date:  2022-08-09       Impact factor: 4.964

3.  Mechanisms underlying diabetic cardiomyopathy: From pathophysiology to novel therapeutic targets.

Authors:  Shuo Cong; Chrishan J A Ramachandra; Kp Myu Mai Ja; Jonathan Yap; Winston Shim; Lai Wei; Derek J Hausenloy
Journal:  Cond Med       Date:  2020-05-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.